|
|
Program Evaluation - Extramural Support
|
ExtraSupport209 [E]
|
$118,090,000
|
$496,000
|
N/A
|
Department of Health and Human Services
|
|
|
Family Studies
|
ZIA CP004410-08285
|
$964,473
|
$48,224
|
A Tucker, Margaret
|
DCEG (NCI)
|
|
|
Gene-environment EBV Interactions in the Etiology of Nasopharyngeal Carcinoma (NP
|
5R01CA115873-02
|
$506,412
|
$506,412
|
ADAMI, HANS-OLOV
|
HARVARD UNIVERSITY (SCH OF PUBLIC HLTH)
|
|
|
Transcriptional Repression of Sodium-Iodide Symporter in Thyroid Carcinoma
|
5R01CA125166-02
|
$126,000
|
$126,000
|
Ain, Kenneth
|
UNIVERSITY OF KENTUCKY
|
|
|
Participation in the Eastern Cooperative Oncology Group
|
5U10CA107868-06
|
$238,147
|
$4,763
|
AISNER, JOSEPH
|
UNIV OF MED/DENT NJ-R W JOHNSON MED SCH
|
|
|
Enhancing Partner Support to Motivate Smokeless Tobacco Users to Quit Via the Web
|
5R21CA131461-02
|
$175,163
|
$175,163
|
Akers, Laura
|
OREGON RESEARCH INSTITUTE
|
|
|
Treatment of Osteoradionecrosis with Bone Marrow Stromal Cells
|
5K08CA120875-04
|
$138,333
|
$138,333
|
AKINTOYE, SUNDAY
|
UNIVERSITY OF PENNSYLVANIA
|
|
|
Prospective study of farmers and their families (Agricultural health study)
|
ZIA CP010119-02020
|
$774,176
|
$38,709
|
Alavanja
|
DCEG (NCI)
|
|
|
ATBC Study
|
ZIA CP010195-03031
|
$804,186
|
$24,126
|
Albanes
|
DCEG (NCI)
|
|
|
Clinical Academic Oncologist Training Program
|
5K12CA087718-10
|
|
$0
|
Albertini, Mark
|
UNIVERSITY OF WISCONSIN MADISON
|
|
|
Genomic and Functional Analysis of Oral Cancer Development
|
5R01CA118323-03
|
$270,375
|
$270,375
|
Albertson, Donna
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
|
Amplicons in Oral Dysplasia
|
5R01CA131286-02
|
$270,000
|
$270,000
|
Albertson, Donna
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
|
Inherited bone marrow failure syndromes study
|
ZIA CP010144-07130
|
$1,042,262
|
$260,565
|
Alter
|
DCEG (NCI)
|
|
|
Characterizing the Role of MYC-MAX Complexes in TORC1/MAML2-mediated Oncogenesis
|
5F32CA134121-02
|
$51,710
|
$51,710
|
Amelio, Antonio
|
SCRIPPS FLORIDA RESEARCH INSTITUTE
|
|
|
Small Molecule Inhibitors of Oncogenic Human Papillomavirus
|
5R01CA119904-02
|
$339,522
|
$115,437
|
ANDROPHY, ELLIOT
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
|
|
Extension of Radiotherapy Research
|
3P01CA006294-44S1
|
$300,000
|
$30,000
|
ANG, K
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
|
EGFR antisense DNA added to cetuximab and radiotherapy for head and neck cancer
|
5R21CA130241-02
|
$344,985
|
$344,985
|
ARGIRIS, ATHANASSIOS
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
|
ADD ARTICLE H.49., EXCHANGE OF CONFIDENTIAL INFORMATION AND RESEARCH MATERIALS
|
N01CO800001-012
|
$231,187,932
|
$10,000
|
ARTHUR, LARRY
|
SAIC-FREDERICK INC:1107088
|
|
|
Southeast Cancer Control Consortium, Inc
|
5U10CA045808-23
|
$2,304,698
|
$23,047
|
ATKINS, JAMES
|
SOUTHEAST CANCER CONTROL CONSORTIUM
|
|
|
Eastern Cooperative Oncology Group
|
5U10CA080775-11
|
$130,866
|
$2,617
|
ATKINS, MICHAEL
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
|
Telomeres, telomerase and chemotherapy: Bench to bedside
|
5R01CA077091-06
|
$346,857
|
$69,371
|
Au, Jessie
|
OPTIMUM THERAPEUTICS, LLC
|
|
|
Eastern Cooperative Oncology Group Studies
|
5U10CA014548-35
|
$417,370
|
$8,347
|
AVERBOOK, BRUCE
|
CASE WESTERN RESERVE UNIVERSITY
|
|
|
Spousal Support, Emotional Disclosure, and Adjustment to Head and Neck Cancer
|
5K07CA124668-03
|
$132,638
|
$132,638
|
BADR, HODA
|
MOUNT SINAI SCHOOL OF MEDICINE OF NYU
|
|
|
DNA-linked dendrimer nanoparticle systems for cancer diagnosis and treatment
|
3R01CA119409-04S1
|
$50,000
|
$15,000
|
Baker, James
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
|
DNA-linked dendrimer nanoparticle systems for cancer diagnosis and treatment
|
5R01CA119409-05
|
$492,995
|
$147,899
|
Baker, James
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
|
Tumor Banking for the Southwest Oncology Group
|
5U24CA114748-05
|
$1,093,403
|
$54,670
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
|
Clinical Pharmacology of Anticancer Drugs
|
ZIA BC 011080
|
$923,641
|
$277,092
|
Balis, Frank
|
CCR (NCI)
|
|
|
Anticancer Drug Development for Childhood Cancers
|
ZIA SC 006880
|
$831,277
|
$124,692
|
Balis, Frank
|
CCR (NCI)
|
|
|
Image-Guided Interventional Cancer Therapy with Liposomal Radionuclides
|
5R01CA131039-02
|
$278,100
|
$278,100
|
BAO, ANDE
|
UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT
|
|
|
The Role of Semaphorin 4D and Plexin-B1 in Tumor-Induced Angiogenesis.
|
1R01CA133162-01A2
|
$311,250
|
$311,250
|
Basile, John
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
|
UPSTATE CAROLINA COMMUNITY CLINICAL ONCOLOGY PROGRAM
|
5U10CA035119-25
|
$1,884,250
|
$18,843
|
BEARDEN, JAMES
|
SPARTANBURG REGIONAL MEDICAL CENTER
|
|
|
The Gulf Coast MBCCOP
|
5U10CA128536-03
|
$507,986
|
$5,080
|
BEEKER, THADDEUS
|
PROVIDENCE HOSPITAL (MOBILE, AL)
|
|
|
Identification and Classification of Epigenetic Changes in Head and Neck Cancer
|
1R21CA131648-01A2
|
$219,120
|
$219,120
|
BELBIN, THOMAS
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
|
Eastern Cooperative Oncology Group Clinical Trials
|
5U10CA017145-34
|
$460,085
|
$9,202
|
BENSON, AL
|
NORTHWESTERN UNIVERSITY
|
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-45S1
|
$124,531
|
$1,245
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-45S2
|
$100,000
|
$1,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-45S5
|
$143,383
|
$1,434
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
|
CANCER CENTER SUPPORT GRANT
|
5P30CA006516-45
|
$11,688,901
|
$116,889
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
|
Geisinger Clinical Oncology Program
|
5U10CA035448-26
|
$610,000
|
$6,100
|
Bernath, Albert
|
WEIS CENTER FOR RESEARCH-GEISINGER CLINC
|
|
|
Research and Mentoring on Energetic Factors and Cancer: Established Investigator
|
1K05CA136967-01A1
|
$131,592
|
$6,580
|
BERNSTEIN, LESLIE
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
|
Studies of Medical Radiation and Other Therapeutic Agents
|
ZIA CP010131-04020
|
$2,310
|
$345
|
Berrington, Amy
|
DCEG (NCI)
|
|
|
Studies of Medical Radiation and Other Therapeutic Agents
|
ZIA CP010131-04033
|
$172,949
|
$17,295
|
Berrington, Amy
|
DCEG (NCI)
|
|
|
Studies of Medical Radiation and Other Therapeutic Agents
|
ZIA CP010131-04140
|
$406,291
|
$20,315
|
Berrington, Amy
|
DCEG (NCI)
|
|
|
Studies of Medical Radiation and Other Therapeutic Agents
|
ZIA CP010131-04150
|
$62,859
|
$1,886
|
Berrington, Amy
|
DCEG (NCI)
|
|
|
Studies of Medical Radiation and Other Therapeutic Agents
|
ZIA CP010131-04175
|
$30,597
|
$12,239
|
Berrington, Amy
|
DCEG (NCI)
|
|
|
Studies of Medical Radiation and Other Therapeutic Agents
|
ZIA CP010131-10430
|
$103,605
|
$103,605
|
Berrington, Amy
|
DCEG (NCI)
|
|
|
Studies of Medical Radiation and Other Therapeutic Agents
|
ZIA CP010131-10441
|
$63,699
|
$12,740
|
Berrington, Amy
|
DCEG (NCI)
|
|
|
Risk factors for thyroid cancer in the NCI cohorts
|
ZIA CP010136-10447
|
$50,433
|
$50,433
|
Berrington
|
DCEG (NCI)
|
|
|
Intensive Smoking Cessation Invervention for Head and Neck Cancer Patients
|
1R01CA120153-01A2
|
$319,550
|
$319,550
|
BLALOCK, JANICE
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
|
Erythropoietin Blockade for the Treatment of Cancer
|
5R01CA135357-02
|
$408,266
|
$134,728
|
Blau, C. Anthony
|
UNIVERSITY OF WASHINGTON
|
|
Total relevant funding to Head and Neck for this search: $77,051,155
|
